{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T17:17:14Z","timestamp":1778692634729,"version":"3.51.4"},"reference-count":23,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007225","name":"Ministry of Science and Technology","doi-asserted-by":"publisher","award":["104-2314-B-075-024-MY3"],"award-info":[{"award-number":["104-2314-B-075-024-MY3"]}],"id":[{"id":"10.13039\/100007225","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011912","name":"Taipei Veterans General Hospital","doi-asserted-by":"crossref","award":["V105B-023"],"award-info":[{"award-number":["V105B-023"]}],"id":[{"id":"10.13039\/501100011912","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","ajconline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.amjcard.2018.08.056","type":"journal-article","created":{"date-parts":[[2018,9,14]],"date-time":"2018-09-14T00:03:19Z","timestamp":1536883399000},"page":"2049-2054","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Usefulness of the CHA2DS2-VASc Score to Predict the Risk of Sudden Cardiac Death and Ventricular Arrhythmias in Patients With Atrial Fibrillation"],"prefix":"10.1016","volume":"122","author":[{"given":"Ling","family":"Kuo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0265-3094","authenticated-orcid":false,"given":"Tze-Fan","family":"Chao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chia-Jen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Su-Jung","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ta-Chuan","family":"Tuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yenn-Jiang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shih-Lin","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Wei","family":"Lo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Feng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fa-Po","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo-Nan","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tzeng-Ji","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7566-1626","authenticated-orcid":false,"given":"Gregory Y.H.","family":"Lip","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shih-Ann","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2018.08.056_bib0001","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1161\/01.CIR.0000083722.42033.0A","article-title":"Increasing trends in hospitalization for atrial fibrillation in the United States, 1985 through 1999: implications for primary prevention","volume":"108","author":"Wattigney","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2018.08.056_bib0002","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1001\/2013.jamainternmed.744","article-title":"Atrial fibrillation and the risk of sudden cardiac death: the atherosclerosis risk in communities study and cardiovascular health study","volume":"173","author":"Chen","year":"2013","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.amjcard.2018.08.056_bib0003","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1161\/CIRCEP.114.002094","article-title":"Atrial fibrillation is an independent risk factor for ventricular fibrillation: a large-scale population-based case-control study","volume":"7","author":"Bardai","year":"2014","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.amjcard.2018.08.056_bib0004","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1161\/CIRCULATIONAHA.112.000491","article-title":"Investigators R-L. Causes of death and influencing factors in patients with atrial fibrillation: a competing-risk analysis from the randomized evaluation of long-term anticoagulant therapy study","volume":"128","author":"Marijon","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2018.08.056_bib0005","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.003735","article-title":"Sudden cardiac death in patients with atrial fibrillation: insights from the ENGAGE AF-TIMI 48 trial","volume":"5","author":"Eisen","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.amjcard.2018.08.056_bib0006","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/j.jacc.2015.07.026","article-title":"Age threshold for increased stroke risk among patients with atrial fibrillation: a nationwide cohort study from Taiwan","volume":"66","author":"Chao","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2018.08.056_bib0007","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.jacc.2014.11.046","article-title":"Should atrial fibrillation patients with 1 additional risk factor of the CHA2DS2-VASc score (beyond sex) receive oral anticoagulation?","volume":"65","author":"Chao","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2018.08.056_bib0008","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1016\/j.jacc.2014.06.1203","article-title":"Using the CHA2DS2-VASc score for refining stroke risk stratification in 'low-risk' Asian patients with atrial fibrillation","volume":"64","author":"Chao","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2018.08.056_bib0009","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.mayocp.2016.03.007","article-title":"Impact on outcomes of changing treatment guideline recommendations for stroke prevention in atrial fibrillation: a nationwide cohort study","volume":"91","author":"Chao","year":"2016","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.amjcard.2018.08.056_bib0010","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1161\/CIRCULATIONAHA.115.019794","article-title":"Use of oral anticoagulants for stroke prevention in patients with atrial fibrillation who have a history of intracranial hemorrhage","volume":"133","author":"Chao","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2018.08.056_bib0011","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1161\/CIRCULATIONAHA.114.013709","article-title":"Rate-control treatment and mortality in atrial fibrillation","volume":"132","author":"Chao","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2018.08.056_bib0012","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1161\/STROKEAHA.116.013880","article-title":"Validation of a modified CHA2DS2-VASc score for stroke risk stratification in Asian patients with atrial fibrillation: a nationwide cohort study","volume":"47","author":"Chao","year":"2016","journal-title":"Stroke"},{"key":"10.1016\/j.amjcard.2018.08.056_bib0013","doi-asserted-by":"crossref","first-page":"30734","DOI":"10.1038\/srep30734","article-title":"European society of cardiology guideline-adherent antithrombotic treatment and risk of mortality in Asian patients with atrial fibrillation","volume":"6","author":"Li","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.amjcard.2018.08.056_bib0014","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.atherosclerosis.2013.11.036","article-title":"Continuation of statin therapy and a decreased risk of atrial fibrillation\/flutter in patients with and without chronic kidney disease","volume":"232","author":"Chang","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.amjcard.2018.08.056_bib0015","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1016\/j.clinthera.2008.09.010","article-title":"Compliance with antithrombotic prescribing guidelines for patients with atrial fibrillation\u2013a nationwide descriptive study in Taiwan","volume":"30","author":"Lin","year":"2008","journal-title":"Clin Ther"},{"key":"10.1016\/j.amjcard.2018.08.056_bib0016","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.001568","article-title":"Antipsychotic drugs and the risk of ventricular arrhythmia and\/or sudden cardiac death: a nation-wide case-crossover study","volume":"4","author":"Wu","year":"2015","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.amjcard.2018.08.056_bib0017","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1161\/CIRCULATIONAHA.114.012717","article-title":"Long-term clinical outcome of major adverse cardiac events in survivors of infective endocarditis: a nationwide population-based study","volume":"130","author":"Shih","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2018.08.056_bib0018","doi-asserted-by":"crossref","first-page":"46445","DOI":"10.1038\/srep46445","article-title":"Risk and prediction of sudden cardiac death and ventricular arrhythmias for patients with atrial fibrillation\u2014a nationwide cohort study","volume":"7","author":"Chao","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.amjcard.2018.08.056_bib0019","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jchf.2013.12.006","article-title":"The association between atrial fibrillation and sudden cardiac death: the relevance of heart failure","volume":"2","author":"Reinier","year":"2014","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.amjcard.2018.08.056_bib0020","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1161\/01.CIR.49.1.32","article-title":"The effects of cycle length on cardiac refractory periods in man","volume":"49","author":"Denes","year":"1974","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2018.08.056_bib0021","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1046\/j.1540-8167.2000.01208.x","article-title":"Association between atrial fibrillation and appropriate implantable cardioverter defibrillator therapy: results from a prospective study","volume":"11","author":"Gronefeld","year":"2000","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.amjcard.2018.08.056_bib0022","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/j.hrthm.2015.04.018","article-title":"Factors predisposing to ventricular proarrhythmia during antiarrhythmic drug therapy for atrial fibrillation in patients with structurally normal heart","volume":"12","author":"Lin","year":"2015","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.amjcard.2018.08.056_bib0023","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914918317612?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914918317612?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:05:39Z","timestamp":1717200339000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914918317612"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":23,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S0002914918317612"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2018.08.056","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Usefulness of the CHA2DS2-VASc Score to Predict the Risk of Sudden Cardiac Death and Ventricular Arrhythmias in Patients With Atrial Fibrillation","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2018.08.056","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}